These findings suggest that DMC inhibits cancer cell migration and invasion by suppressing the PI3K/Akt and NF-κB signaling pathways, highlighting its potential as a novel anti-metastasis agent for glioblastoma treatment. The gene discussed is AKT1; the disease is glioblastoma.